Alexander R. Giaquinto

Founder at ARG Consulting LLC

Alexander R. Giaquinto

Alexander R. Giaquinto

Founder at ARG Consulting LLC

Overview
Career Highlights

Caldwell College
ARG Consulting LLC

RelSci Relationships

925

Number of Boards

16

Birthday

1944

Age

75

Relationships
RelSci Relationships are individuals Alexander R. Giaquinto likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Financial Officer & Director at Biothera, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Director at Biothera, Inc.

Relationship likelihood: Strong

Vice Chair at Caldwell College

Relationship likelihood: Strong

Vice President Dean Academic Affairs & Secretary at Fontbonne University

Relationship likelihood: Strong

Chairman-Court at American Friends of London School of Hygiene & Tropical Medicine, Inc.

Relationship likelihood: Strong

Former Chief Financial Officer, Vice President & Head-Investor Relations at SurModics, Inc.

Relationship likelihood: Strong

Former Professional at United States Navy

Relationship likelihood: Strong

Chief Executive Officer at Association of Affiliated Pharmacies and Apothecaries

Relationship likelihood: Strong

Former President, Chief Executive Officer & Director at SemBioSys Genetics, Inc.

Relationship likelihood: Strong

Secretary at Caldwell College

Relationship likelihood: Strong

In The News
South Florida Sun-Sentinel
October 7, 2016
Hamilton flies in 'Silver Skies'
The New York Times
September 10, 2016
You're Soaking in It
St. Paul Pioneer Press (Minnesota)
July 25, 2015
Business briefing: Sunday, July 26
Paths to Alexander R. Giaquinto
Potential Connections via
Relationship Science
You
Alexander R. Giaquinto
Founder at ARG Consulting LLC
Education
B.Sc. in Pharmacy

St. John's is one of America's leading Catholic universities – recognized for its superb academic programs, diverse student life, BIG EAST excitement and New York vitality. Founded in 1870 by the Vincentian Community, St. John's is known for giving students the knowledge, skills and confidence to serve others while achieving personal and professional success. Graduates become leaders in their professions, their communities and the world.

Ph.D. in Pharmaceutics

The University of Connecticut (UConn) is a public research university in Connecticut. Known as a Public Ivy,[3] UConn was founded in 1881 and is a Land Grant and Sea Grant college & member of the Space Grant Consortium. The institution serves more than 30,000 students on its six campuses, including more than 8,000 graduate students in multiple programs.[4] UConn's main campus is in Storrs, Connecticut. The university's president is Susan Herbst.[5] UConn is one of the founding institutions of the Hartford, Connecticut/Springfield, Massachusetts regional economic and cultural partnership alliance known as New England's Knowledge Corridor. UConn is a member of Universitas 21, a global network of 24 research-intensive universities, who work together to foster global citizenship and institutional innovation through research-inspired teaching and learning, student mobility, connecting students and staff, and promote advocacy for internationalisation.[6] UConn is accredited by the New England Association of Schools and Colleges.

Memberships
Member
Prior

The New York Academy of Sciences is a membership organization with over 25,000 members in 140 countries. They include research scientists at universities and industry, as well as representatives of business, government, and policy organizations. Our Board of Governors and President's Council include 27 Nobel laureates and other prominent leaders of academia and industry, based in New York and around the world.

Member
Prior
Career History
Founder
Current
Chair
Tenure Unconfirmed

THE EXEMPT PURPOSE IS TO PREPARE STUDENTS THROUGH THE LIBERAL ARTS AND PROFESSIONAL STUDIES TO THINK CRITICALLY, PURSUE TRUTH, AND CONTRIBUTE TO A JUST SOCIETY.

Chief Compliance Officer & Senior Vice President-Regulatory Affairs
2008 - 2014

Regado Biosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of therapies in cardiovascular medicine using actively controlled aptamer technology. The company is focusing on new products for antithrombotic indications in the acute care and sub-acute care therapeutic setting. Its paired aptamer-active control agent technology is designed to give physicians the ability to directly control the degree of antithrombotic activity in real time on a \"per patient, per setting\" basis. The company's clinical programs are specifically concentrated on acute and sub-acute care injectable anticoagulants. Regado Biosciences was founded by Eli Gilboa, Bruce A. Sullenger and Christopher P. Rusconi on December 19, 2001 and is headquartered in Basking Ridge, NJ.

Boards & Committees
Member, Board of Directors
2015 - Current
Director
Current

EndoCeutics, Inc. develops hormone therapies. It offers products for vulvovaginal atrophy-sexual dysfunction, treatment of hot flushes and loss of bone, breast cancer treatment, treatment of endometriosis, treatment of prostate cancer, and male hypogonadism. The company was founded on July 26, 2006 and is headquartered in Quebec, Canada.

Member-Advisory Board
Current
Founding Member-Steering Committee
Current
Chair
Tenure Unconfirmed

THE EXEMPT PURPOSE IS TO PREPARE STUDENTS THROUGH THE LIBERAL ARTS AND PROFESSIONAL STUDIES TO THINK CRITICALLY, PURSUE TRUTH, AND CONTRIBUTE TO A JUST SOCIETY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Alexander R. Giaquinto. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Alexander R. Giaquinto's profile does not indicate a business or promotional relationship of any kind between RelSci and Alexander R. Giaquinto.